These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24767719)

  • 1. Short course daily prednisolone therapy during an upper respiratory tract infection in children with relapsing steroid-sensitive nephrotic syndrome (PREDNOS 2): protocol for a randomised controlled trial.
    Webb NJ; Frew E; Brettell EA; Milford DV; Bockenhauer D; Saleem MA; Christian M; Hall AS; Koziell A; Maxwell H; Hegde S; Finlay ER; Gilbert RD; Booth J; Jones C; McKeever K; Cook W; Ives NJ;
    Trials; 2014 Apr; 15():147. PubMed ID: 24767719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT.
    Webb NJ; Woolley RL; Lambe T; Frew E; Brettell EA; Barsoum EN; Trompeter RS; Cummins C; Wheatley K; Ives NJ
    Health Technol Assess; 2019 May; 23(26):1-108. PubMed ID: 31156083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daily low-dose prednisolone to prevent relapse of steroid-sensitive nephrotic syndrome in children with an upper respiratory tract infection: PREDNOS2 RCT.
    Christian MT; Webb NJ; Woolley RL; Afentou N; Mehta S; Frew E; Brettell EA; Khan AR; Milford DV; Bockenhauer D; Saleem MA; Hall AS; Koziell A; Maxwell H; Hegde S; Finlay ER; Gilbert RD; Jones C; McKeever K; Cook W; Ives N
    Health Technol Assess; 2022 Jan; 26(3):1-94. PubMed ID: 35060851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation.
    Webb NJA; Woolley RL; Lambe T; Frew E; Brettell EA; Barsoum EN; Trompeter RS; Cummins C; Deeks JJ; Wheatley K; Ives NJ;
    BMJ; 2019 May; 365():l1800. PubMed ID: 31335316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Daily Low-Dose Prednisolone During Upper Respiratory Tract Infection to Prevent Relapse in Children With Relapsing Steroid-Sensitive Nephrotic Syndrome: The PREDNOS 2 Randomized Clinical Trial.
    Christian MT; Webb NJA; Mehta S; Woolley RL; Afentou N; Frew E; Brettell EA; Khan AR; Milford DV; Bockenhauer D; Saleem MA; Hall AS; Koziell A; Maxwell H; Hegde S; Prajapati H; Gilbert RD; Jones C; McKeever K; Cook W; Ives N
    JAMA Pediatr; 2022 Mar; 176(3):236-243. PubMed ID: 34928294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short courses of daily prednisolone during upper respiratory tract infections reduce relapse frequency in childhood nephrotic syndrome.
    Abeyagunawardena AS; Thalgahagoda RS; Dissanayake PV; Abeyagunawardena S; Illangasekera YA; Karunadasa UI; Trompeter RS
    Pediatr Nephrol; 2017 Aug; 32(8):1377-1382. PubMed ID: 28341877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing the dose of prednisolone during viral infections reduces the risk of relapse in nephrotic syndrome: a randomised controlled trial.
    Abeyagunawardena AS; Trompeter RS
    Arch Dis Child; 2008 Mar; 93(3):226-8. PubMed ID: 17573408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. REducing STEroids in Relapsing Nephrotic syndrome: the RESTERN study- protocol of a national, double-blind, randomised, placebo-controlled, non-inferiority intervention study.
    Schijvens AM; Dorresteijn EM; Roeleveld N; Ter Heine R; van Wijk JAE; Bouts AHM; Keijzer-Veen MG; van de Kar NCAJ; van den Heuvel LPWJ; Schreuder MF
    BMJ Open; 2017 Sep; 7(9):e018148. PubMed ID: 28963315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial).
    Hama T; Nakanishi K; Ishikura K; Ito S; Nakamura H; Sako M; Saito-Oba M; Nozu K; Shima Y; Iijima K; Yoshikawa N;
    BMC Nephrol; 2018 Sep; 19(1):223. PubMed ID: 30200895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of low-dose daily versus alternate-day prednisolone in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.
    Yadav M; Sinha A; Khandelwal P; Hari P; Bagga A
    Pediatr Nephrol; 2019 May; 34(5):829-835. PubMed ID: 30194663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a low-dose prednisolone regimen to treat a relapse of steroid-sensitive nephrotic syndrome in children.
    Raja K; Parikh A; Webb H; Hothi D
    Pediatr Nephrol; 2017 Jan; 32(1):99-105. PubMed ID: 27677978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daily corticosteroids reduce infection-associated relapses in frequently relapsing nephrotic syndrome: a randomized controlled trial.
    Gulati A; Sinha A; Sreenivas V; Math A; Hari P; Bagga A
    Clin J Am Soc Nephrol; 2011 Jan; 6(1):63-9. PubMed ID: 20847092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children.
    Larkins N; Kim S; Craig J; Hodson E
    Arch Dis Child; 2016 Apr; 101(4):404-8. PubMed ID: 26289063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07).
    Horinouchi T; Sako M; Nakanishi K; Ishikura K; Ito S; Nakamura H; Oba MS; Nozu K; Iijima K
    BMC Nephrol; 2018 Nov; 19(1):302. PubMed ID: 30382824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of relapses with levamisole as adjuvant therapy in children with a first episode of idiopathic nephrotic syndrome: study protocol for a double blind, randomised placebo-controlled trial (the LEARNS study).
    Veltkamp F; Khan DH; Reefman C; Veissi S; van Oers HA; Levtchenko E; Mathôt RAA; Florquin S; van Wijk JAE; Schreuder MF; Haverman L; Bouts AHM
    BMJ Open; 2019 Aug; 9(8):e027011. PubMed ID: 31375606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-Duration Prednisolone in Children with Nephrotic Syndrome Relapse: A Noninferiority Randomized Controlled Trial.
    Kainth D; Hari P; Sinha A; Pandey S; Bagga A
    Clin J Am Soc Nephrol; 2021 Feb; 16(2):225-232. PubMed ID: 33478976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extending initial prednisolone treatment in a randomized control trial from 3 to 6 months did not significantly influence the course of illness in children with steroid-sensitive nephrotic syndrome.
    Sinha A; Saha A; Kumar M; Sharma S; Afzal K; Mehta A; Kalaivani M; Hari P; Bagga A
    Kidney Int; 2015 Jan; 87(1):217-24. PubMed ID: 25029428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose versus conventional-dose prednisolone for nephrotic syndrome relapses: a randomized controlled non-inferiority trial.
    Sheikh S; Mishra K; Kumar M
    Pediatr Nephrol; 2021 Oct; 36(10):3143-3150. PubMed ID: 33861375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial.
    Iijima K; Sako M; Nozu K; Mori R; Tuchida N; Kamei K; Miura K; Aya K; Nakanishi K; Ohtomo Y; Takahashi S; Tanaka R; Kaito H; Nakamura H; Ishikura K; Ito S; Ohashi Y;
    Lancet; 2014 Oct; 384(9950):1273-81. PubMed ID: 24965823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticosteroid therapy for nephrotic syndrome in children.
    Hodson EM; Knight JF; Willis NS; Craig JC
    Cochrane Database Syst Rev; 2003; (1):CD001533. PubMed ID: 12535410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.